Israel Active

I reported previously when retired surgeon Norman Rosenbaum was awarded by UK PM Theresa May for helping to buy 11 ambulances for Israeli emergency service Magen David Adom. Norman has just fundraised his 12th ambulance for MDA who awarded him Humanitarian of the Year.

A recent study of Go-Less Men (EFLA940 - an extract from pumpkin seeds) to be effective in the treatment of symptoms of BHP (Benign Prostatic Hyperplasia). Go-Less is marketed by Israel-founded Frutarom. A previous study showed Go-Less to relieve incontinence in women.

At Israel’s Weizmann Institute there are over 60 research groups focusing on beating cancer and over 40% of the Institute’s life sciences research is cancer-related.

This article gives an excellent description of the process used by Israel’s Insightec to treat the symptoms of Parkinson’s and Essential Tremor patients. The technology is being used in over 50 medical centers around the world and has treated over 2,000 neuro-patients.

Researchers at Tel Aviv University have unveiled the world’s first 3D-printed heart using human tissue that contains cells, blood vessels, ventricles and chambers. Although there are still many challenges ahead, fully working 3D printed hearts will one day be available for transplant into patients.

I reported previously on Israel’s Medial EarlySign’s and its use of AI to search the data of Israeli health company Maccabi to detect patients with colon cancer. In the last 18 months, Medial’s algorithms have flagged 67 patients with colon cancer and 250 in a pre-colon cancer state.

Surgeons at Israel’s Hillel Yaffe Medical Center performed the first reconstruction of a bone segment with a custom titanium implant, printed on a 3D printer.

Israel’s Epitomee Medical is developing an orally administered “shape-shifting” capsule that works on the stomach through mechanosensory stimulation. It is intended to prolong the gastric emptying process of prediabetics and moderately obese patients, giving them the sensation of being full.

Tel Aviv University researchers have discovered why Parkinson’s patients have difficulty transitioning from walking through turning around to sitting. It has led to new advice for patients that when turning to sit down, they should first turn, briefly stop, and then sit down.

Israel’s Weizmann Institute is partnering Institut Curie in Paris to advance knowledge and discovery in life sciences, physics and chemistry, focusing on cancer research. The new partnership also extends to cellular biology, epigenetics, genetics, immunology, single-cell sequencing.